NAVITRUX
Generic: FOSAPREPITANT
AVYXA PharmaManufacturer
INTRAVENOUSRoute
FOSAPREPITANT DIMEGLUMINEActive Substance
2026-06-24Original Approval
NAVITRUX is FDA application NDA220436, sponsored by AVYXA HOLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
321 reports
2
INFUSION RELATED REACTION
277 reports
3
ALOPECIA
250 reports
4
FATIGUE
238 reports
5
HYPERSENSITIVITY
232 reports
6
ARTHRALGIA
224 reports
7
PYREXIA
223 reports
8
CONFUSIONAL STATE
219 reports
9
DUODENAL ULCER PERFORATION
213 reports
10
NAUSEA
212 reports